← Leaderboards
Daniel Raphael Saban
Schepens Eye Research Institute
$11,073,426
Attributed
$14,443,191
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,443,191 · 7
By mechanism
R01$8,220,421 · 2
U01$5,054,648 · 1
P30$1,062,602 · 3
F32$105,520 · 1
Top collaborators
- Sina Farsiu4 shared
- Victor L Perez4 shared
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Darlene A Dartt$22,271,016
- David A Sullivan$9,500,346
- Fu-Shin X Yu$14,544,558
- Santa Jeremy Ono$2,673,380
- Ilene K. Gipson$11,024,212
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsVisionMediatingPathologyIn VivoImmunePlayOcular SurfaceImmune ResponseMolecularFlow CytometryPhenotypeData SetGeneticComputer SoftwareAllergicQuality Of LifeBaseResponsePathogenesisExperimental StudyComplexNew Therapeutic Target
Grant awards (37)
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,105,585
U01 · FY2025 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$579,548
R01 · FY2025 · EY · contact PI
Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune Diseases$398,756
R01 · FY2025 · EY · contact PI
Flow Cytometry Module$128,642
P30 · FY2025 · EY · contact PI
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,300,835
U01 · FY2024 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$605,942
R01 · FY2024 · EY · contact PI
Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune Diseases$398,756
R01 · FY2024 · EY · contact PI
Flow Cytometry Module$128,642
P30 · FY2024 · EY · contact PI
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,305,707
U01 · FY2023 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$440,728
R01 · FY2023 · EY · contact PI
Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune Diseases$398,756
R01 · FY2023 · EY · contact PI
Flow Cytometry Module$128,642
P30 · FY2023 · EY · contact PI
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,342,521
U01 · FY2022 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$432,190
R01 · FY2022 · EY · contact PI
Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune Diseases$398,756
R01 · FY2022 · EY · contact PI
Flow Cytometry Module$128,642
P30 · FY2022 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$443,123
R01 · FY2021 · EY · contact PI
Flow Cytometry Module$128,642
P30 · FY2021 · EY · contact PI
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration$451,998
R01 · FY2020 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Disease during Severe Allergic Inflammation$397,500
R01 · FY2020 · EY · contact PI
Flow Cytometry Core$83,720
P30 · FY2020 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Disease during Severe Allergic Inflammation$397,500
R01 · FY2019 · EY · contact PI
Flow Cytometry Core$83,720
P30 · FY2019 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Disease during Severe Allergic Inflammation$397,500
R01 · FY2018 · EY · contact PI
Flow Cytometry Core$83,720
P30 · FY2018 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Disease during Severe Allergic Inflammation$397,500
R01 · FY2017 · EY · contact PI
Flow Cytometry Core$83,720
P30 · FY2017 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$451,534
R01 · FY2016 · EY · contact PI
Flow Cytometry Core$84,512
P30 · FY2016 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$346,185
R01 · FY2015 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$80,089
R01 · FY2015 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$346,185
R01 · FY2014 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$372,875
R01 · FY2013 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$388,000
R01 · FY2012 · EY · contact PI
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy$97,000
R01 · FY2012 · EY · contact PI
Composite Allografting for Promoting Survival of Corneal Transplants$53,810
F32 · FY2010 · EY · contact PI
Composite Allografting for Promoting Survival of Corneal Transplants$51,710
F32 · FY2009 · EY · contact PI